Answer:
The profit margin controllable by the Central Valley segment manager is: $ 95,000.
Explanation:
Only items directly controllable by the Manager should be included in the divisional financial performance measure.
<u>Central Valley Division</u>
Revenues $ 405,000
Less Variable Costs :
Variable operating expenses ($ 230,000)
Controllable Contribution $ 175,000
Less Controllable fixed expenses ($80,000)
Controllable Profit $ 95,000
Answer: True
Explanation:
Variable selling and administrative expenses increase with the number of sales so in order to get them, one needs to multiply the number of sales by the variable and administrative expenses.
This also goes for the budgeted variable selling expenses. To find out these costs, multiply the expected variable and admin expenses by the budgeted number of sales. The amount you get will show the amount of variable expenses to budget based on the sales you budgeted.
Answer:
Total utility is 50
Explanation:
Mathematically;
TU = U1+MU2+MU3+MU4+MU5
TU = Total utility
U1= utility of 1st product of good Y
MU2= Marginal utility of 2nd product of good Y.............
MU5= Marginal utility of 5th product of good Y
Solution:
TUy= 15+15+10+7+3
TUy= 50.
Answer:
a. $69.46
b. 58.15
Explanation:
a. Price = Benchmark PS ratio × Sales per share
<u>Sales per Share</u>
= Sales / Shares outstanding
= 2,100,000/130,000
= $16.15
Price = 4.3 * 16.15
Price = $69.46
b. PS Ratio is 3.6
Price = Benchmark PS ratio × Sales per share
Price = 3.6 * 16.15
Price = $58.15
Since Intel has a history of effectively transforming
R&D investment into income, the pro-forma version of the ration seems to be
of more significant. A company starting, for instance, would be unalike: its
track record would be much poorer and probabilities are that the criteria set
in place would not be as rough as Intel’s. Therefore, it appears that the significance
hinge on the kind of business: if future benefit is more of a doubt, then
R&D should be expensed. The contradictory is true if benefit is almost certain.
Intel also has the advantage of being very vibrant with its R&D objectives
and having exact, measurable standards. They note obviously what the funds are apportioned
to and what the end outcomes should be of the growth.
